Free Trial

Cingulate (CINGW) Competitors

$0.10 +0.05 (+110.87%)
As of 07/18/2025 03:33 PM Eastern

CINGW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CALA

Should you be buying Cingulate stock or one of its competitors? The main competitors of Cingulate include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

Cingulate vs. Its Competitors

Cingulate (NASDAQ:CINGW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, Cingulate's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Cingulate Neutral
180 Life Sciences Neutral

Summary

Cingulate and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Get Cingulate News Delivered to You Automatically

Sign up to receive the latest news and ratings for CINGW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CINGW vs. The Competition

MetricCingulateBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$129.53M$5.54B$9.40B
Dividend YieldN/A3.74%3.75%4.03%
P/E RatioN/A3.5928.0119.77
Price / SalesN/A4,198.65432.5597.25
Price / CashN/A13.1936.1658.27
Price / BookN/A37.888.125.65
Net IncomeN/A-$90.99M$3.25B$257.91M
7 Day PerformanceN/A0.74%1.64%3.35%
1 Month PerformanceN/A5.26%7.27%11.09%
1 Year PerformanceN/A173.84%32.88%18.99%

Cingulate Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CINGW
Cingulate
N/A$0.10
+110.9%
N/AN/A$0.00N/A0.0020Positive News
Gap Up
High Trading Volume
ATNFW
180 Life Sciences
N/A$0.01
-12.0%
N/A-15.6%$0.00N/A0.007Positive News
Gap Down
High Trading Volume
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.18
+5.9%
N/AN/A$0.00$106.21K0.0040Positive News
Gap Up
ALVOW
Alvotech
N/A$1.80
+13.2%
N/A-33.7%$0.00$585.60M0.004Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.04
+75.5%
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
+2.9%
N/A+99.8%$0.00$38.00M0.0070Positive News
BTMDW
biote
N/A$0.01
+16.1%
N/A-97.3%$0.00$199.38M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.04
-4.6%
N/A-68.0%$0.00N/A0.008Positive News
Gap Up
CALA
Calithera Biosciences
N/A$0.00
flat
N/A-99.2%$0.00N/A0.0060

Related Companies and Tools


This page (NASDAQ:CINGW) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners